Physician profile
John J Jasko
NPI 1891795209
$39,052.56
in general payments reported to CMS, 2019-2025
15 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,467 · 2020: $1,793 · 2021: $2,068 · 2022: $5,887 · 2023: $5,499 · 2024: $6,434 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $8,195 · Food and Beverage: $4,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,508.75 |
| Travel and Lodging | $8,194.73 |
| Food and Beverage | $4,133.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $11,811.57 | 2019-2024 | |
| Encore Medical, Lp | $11,774.06 | 2024-2025 | Djo Surgical |
| Stryker Corporation | $10,000.03 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Flex Revive, Pangea |
| Zimmer Biomet Holdings, INC. | $2,167.46 | 2019-2023 | Comprehensive Shoulder System |
| Arthrex, INC. | $1,467.64 | 2022-2023 | |
| Exactech, INC. | $1,090.23 | 2019 | |
| Smith+Nephew, INC. | $257.95 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Mini-Open Latarjet, Spatial Frame |
| Vericel Corporation | $147.81 | 2023 | Maci |
| Linvatec Corporation | $84.96 | 2025 | Biobrace 23mm |
| Pacira Pharmaceuticals Incorporated | $58.86 | 2024-2025 | Zilretta, Iovera |
| Catalyst Orthoscience | $51.04 | 2023 | R1 Reverse Total Shoulder, Archer 3d Software, Csr & R1 Reverse Total Shoulder Systems |
| Bioventus LLC | $48.55 | 2019-2025 | Xcell |
| Ferring Pharmaceuticals INC. | $39.09 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $35.22 | 2024-2025 | |
| Pacira Therapeutics, INC. | $18.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jasko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.